// App-Quantinova.ai

: Brentuximab in Children, Adolescent and Young Adults with Relapsed/Refractory Anaplastic Large Cell Lymphoma

Researchers

Presenter

  • Luciana Vinti

Principal Investigators

  • Pietro Merli

  • Emanuele Agolini

  • Francesca Stocchi

  • Barbarella Lucarelli

  • Katia Girardi

  • Mattia Algeri

  • Emilia Boccieri

  • Mariachiara Lodi

  • Marco Becilli

  • Maria Giuseppina Cefalo

Medical Centers

  • Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy

  • Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, IRRCS Ospedale Pediatrico Bambino Gesù, Rome, Italy

  • Bambino Gesù Children's Hospital, IRCCS, Rome, ITA

  • IRCCS Bambino Gesù Children Hospital, Rome, ITA

Locations

  • Italy

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • Bendamustine

  • Adcetris

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A